Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Helsinki University Central Hospital
Information provided by (Responsible Party):
Hanna Mäenpää, Helsinki University
ClinicalTrials.gov Identifier:
NCT00115895
First received: June 26, 2005
Last updated: March 18, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2020
  Primary Completion Date: October 2004 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):